Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Davis

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Managed Care (Langhorne, Pa.)|April 6, 2010
Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipationShrividya Iyer, Keith L Davis, Sean Candrilli
Postgraduate Medicine|May 14, 2011
All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndromeDebanjali Mitra, Keith L Davis, Robert W Baran
Journal of Pain & Palliative Care Pharmacotherapy|August 12, 2009
Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapySean D Candrilli, Keith L Davis, Shrividya Iyer
Human Vaccines & Immunotherapeutics|September 8, 2017
Effect of combination vaccines on completion and compliance of childhood vaccinations in the United StatesSamantha K Kurosky, Keith L Davis, Girishanthy Krishnarajah
Vaccine|November 25, 2015
Completion and compliance of childhood vaccinations in the United StatesSamantha K Kurosky, Keith L Davis, Girishanthy Krishnarajah
Human Vaccines|July 29, 2011
Cost impact of complications in meningococcal disease: evidence from a United States managed care populationKeith L Davis, Derek Misurski, Jacqueline Miller, et al.
Managed Care (Langhorne, Pa.)|September 6, 2011
Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPDAnand A Dalal, Sean D Candrilli, Keith L Davis
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2010
Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims dataKeith L Davis, Heather M Edin, Jeffery K Allen
Epilepsia|November 23, 2007
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care populationKeith L Davis, Sean D Candrilli, Heather M Edin
BMJ Open|August 3, 2013
Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIVCalvin J Cohen, Juliana L Meyers, Keith L Davis
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Managed Care (Langhorne, Pa.)|April 6, 2010
Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipationShrividya Iyer, Keith L Davis, Sean Candrilli
Postgraduate Medicine|May 14, 2011
All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndromeDebanjali Mitra, Keith L Davis, Robert W Baran
Journal of Pain & Palliative Care Pharmacotherapy|August 12, 2009
Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapySean D Candrilli, Keith L Davis, Shrividya Iyer
Human Vaccines & Immunotherapeutics|September 8, 2017
Effect of combination vaccines on completion and compliance of childhood vaccinations in the United StatesSamantha K Kurosky, Keith L Davis, Girishanthy Krishnarajah
Vaccine|November 25, 2015
Completion and compliance of childhood vaccinations in the United StatesSamantha K Kurosky, Keith L Davis, Girishanthy Krishnarajah
Human Vaccines|July 29, 2011
Cost impact of complications in meningococcal disease: evidence from a United States managed care populationKeith L Davis, Derek Misurski, Jacqueline Miller, et al.
Managed Care (Langhorne, Pa.)|September 6, 2011
Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPDAnand A Dalal, Sean D Candrilli, Keith L Davis
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2010
Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims dataKeith L Davis, Heather M Edin, Jeffery K Allen
Epilepsia|November 23, 2007
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care populationKeith L Davis, Sean D Candrilli, Heather M Edin
BMJ Open|August 3, 2013
Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIVCalvin J Cohen, Juliana L Meyers, Keith L Davis
Pageof 9